Skip to main content
Top
Published in: Polymer Bulletin 10/2017

23-02-2017 | Original Paper

In vivo study of hybrid biomaterial scaffold bioactive glass–chitosan after incorporation of Ciprofloxacin

Authors: Salha Boulila, Hassane Oudadesse, Rim Kallel, Bertrand Lefeuvre, Mostafa Mabrouk, Khansa Chaabouni, Fatma Makni-Ayedi, Tahia Boudawara, Abdelfattah Elfeki, Hafed Elfeki

Published in: Polymer Bulletin | Issue 10/2017

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

The present study aimed to evaluate the effect of bioactive glass as well as the presence of Ciprofloxacin drug (%Cip) into bioactive glass–chitosan composite on the in vivo behavior of these scaffolds. These scaffolds were implanted in the femoral condyl of an ovariectomized rat. The serum and organs (liver and kidney) of the under investigated rats were analyzed. Also the physicochemical properties of the prepared implants were assessed using Fourier transform infrared spectroscopy (FT-IR) and X-ray diffraction (XRD) before and after implantation (at different periods of implantation). Biochemical and histological analyses of the under investigated rats proved the biocompatibility of the prepared scaffolds. The hydroxyapatite like layer was significantly precipitated on the surface of BG–CH scaffold than BG–CH–20Cip. In this same period, FT-IR of BG–CH shows complete disappearance of Si–O–Si. Their characteristics bands were replaced by P–O group arisen form bone apatite bands. Physicochemical results show progressive degradation of BG–CH and BG–CH–20Cip that occurred at the same time as replacement of the implant by an apatite layer. However, the bioresorbability and bioactivity of BG–CH are faster than those of BG–CH–20Cip. Therefore, the incorporation of the Ciprofloxacin in the BG–CH induces a retarding effect on the formation of the hydroxyapatite, and consequently on the ossification, without any side effects on the liver–kidney.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
3.
go back to reference McKee MD (2006) Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 14:S163–S167CrossRef McKee MD (2006) Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 14:S163–S167CrossRef
6.
go back to reference Dorea HC, McLaughlin RM, Cantwell HD et al (2005) Evaluation of healing in feline femoral defects filled with cancellous autograft, cancellous allograft or bioglass. Vet Comp Orthop Traumatol VCOT 18:157–168 Dorea HC, McLaughlin RM, Cantwell HD et al (2005) Evaluation of healing in feline femoral defects filled with cancellous autograft, cancellous allograft or bioglass. Vet Comp Orthop Traumatol VCOT 18:157–168
7.
go back to reference Neo M, Nakamura T, Ohtsuki C et al (1994) Ultrastructural study of the A-W GC-bone interface after long-term implantation in rat and human bone. J Biomed Mater Res 28:365–372. doi:10.1002/jbm.820280311 CrossRef Neo M, Nakamura T, Ohtsuki C et al (1994) Ultrastructural study of the A-W GC-bone interface after long-term implantation in rat and human bone. J Biomed Mater Res 28:365–372. doi:10.​1002/​jbm.​820280311 CrossRef
8.
go back to reference Pajamäki KJ, Andersson OH, Lindholm TS et al (1993) Induction of new bone by allogeneic demineralized bone matrix combined to bioactive glass composite in the rat. Ann Chir Gynaecol Suppl 207:137–143 Pajamäki KJ, Andersson OH, Lindholm TS et al (1993) Induction of new bone by allogeneic demineralized bone matrix combined to bioactive glass composite in the rat. Ann Chir Gynaecol Suppl 207:137–143
10.
go back to reference Dash AK, Suryanarayanan R (1992) An implantable dosage form for the treatment of bone infections. Pharm Res 9:993–1002CrossRef Dash AK, Suryanarayanan R (1992) An implantable dosage form for the treatment of bone infections. Pharm Res 9:993–1002CrossRef
12.
go back to reference Dash AK, Cudworth GC (1998) Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 40:1–12CrossRef Dash AK, Cudworth GC (1998) Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 40:1–12CrossRef
13.
go back to reference Otsuka M, Matsuda Y, Yu D et al (1990) A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. Chem Pharm Bull (Tokyo) 38:3500–3502CrossRef Otsuka M, Matsuda Y, Yu D et al (1990) A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement. Chem Pharm Bull (Tokyo) 38:3500–3502CrossRef
14.
go back to reference Yu D, Wong J, Matsuda Y et al (1992) Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system for antibiotics. J Pharm Sci 81:529–531CrossRef Yu D, Wong J, Matsuda Y et al (1992) Self-setting hydroxyapatite cement: a novel skeletal drug-delivery system for antibiotics. J Pharm Sci 81:529–531CrossRef
15.
16.
go back to reference Mabrouk M, Mostapaha AA, Oudadesse H et al (2013) Fabrication, characterization and drug release of Ciprofloxacin loaded porous polyvinyl alcohol/bioactive glass scaffold for controlled drug delivery. Bioceram Dev Appl S:1–4. doi:10.4172/2090-5025.S1-009 Mabrouk M, Mostapaha AA, Oudadesse H et al (2013) Fabrication, characterization and drug release of Ciprofloxacin loaded porous polyvinyl alcohol/bioactive glass scaffold for controlled drug delivery. Bioceram Dev Appl S:1–4. doi:10.​4172/​2090-5025.​S1-009
18.
go back to reference Lebecq I (2002) Etude de bioverres à base de SiO2, CaO, Na2O non dopés et dopés par le phosphore. Valenciennes Lebecq I (2002) Etude de bioverres à base de SiO2, CaO, Na2O non dopés et dopés par le phosphore. Valenciennes
20.
go back to reference Oudadesse H, Bui XV, Le Gal Y et al (2011) Chitosan effects on bioactive glass for application as biocopmosite biomaterial. Int J Biol Biomed Eng 5:49–56 Oudadesse H, Bui XV, Le Gal Y et al (2011) Chitosan effects on bioactive glass for application as biocopmosite biomaterial. Int J Biol Biomed Eng 5:49–56
22.
go back to reference Zimpfer A, Propst A, Mikuz G et al (2004) Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch Int J Pathol 444:87–89CrossRef Zimpfer A, Propst A, Mikuz G et al (2004) Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch Int J Pathol 444:87–89CrossRef
23.
go back to reference Alshammari TM, Larrat EP, Morrill HJ et al (2014) Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 71:37–43. doi:10.2146/ajhp130165 CrossRef Alshammari TM, Larrat EP, Morrill HJ et al (2014) Risk of hepatotoxicity associated with fluoroquinolones: a national case-control safety study. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 71:37–43. doi:10.​2146/​ajhp130165 CrossRef
24.
go back to reference Chaibdraa A, Medjellekh MS, Saouli A, Bentakouk MC (2008) Le Pseudomonas: experience du Centre des Brules D’Annaba et Revue de la Litterature. Ann Burns Fire Disasters 21:210–218 Chaibdraa A, Medjellekh MS, Saouli A, Bentakouk MC (2008) Le Pseudomonas: experience du Centre des Brules D’Annaba et Revue de la Litterature. Ann Burns Fire Disasters 21:210–218
25.
go back to reference Tamilvanan S, Venkateshan N, Ludwig A (2008) The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release Off J Control Release Soc 128:2–22. doi:10.1016/j.jconrel.2008.01.006 CrossRef Tamilvanan S, Venkateshan N, Ludwig A (2008) The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release Off J Control Release Soc 128:2–22. doi:10.​1016/​j.​jconrel.​2008.​01.​006 CrossRef
26.
go back to reference Lomaestro BM (2000) Fluoroquinolone-induced renal failure. Drug Saf 22:479–485CrossRef Lomaestro BM (2000) Fluoroquinolone-induced renal failure. Drug Saf 22:479–485CrossRef
27.
go back to reference Usami Y, Okamoto Y, Minami S et al (1994) Chitin and chitosan induce migration of bovine polymorphonuclear cells. J Vet Med Sci Jpn Soc Vet Sci 56:761–762CrossRef Usami Y, Okamoto Y, Minami S et al (1994) Chitin and chitosan induce migration of bovine polymorphonuclear cells. J Vet Med Sci Jpn Soc Vet Sci 56:761–762CrossRef
28.
go back to reference Usami Y, Okamoto Y, Minami S et al (1994) Migration of canine neutrophils to chitin and chitosan. J Vet Med Sci Jpn Soc Vet Sci 56:1215–1216CrossRef Usami Y, Okamoto Y, Minami S et al (1994) Migration of canine neutrophils to chitin and chitosan. J Vet Med Sci Jpn Soc Vet Sci 56:1215–1216CrossRef
29.
go back to reference Wu H, Zheng O, Du J et al (1997) A new drug delivery system—Ciprofloxacine/tricalcium phosphate delivery capsule (CTDC) and its in vitro drug release pattern. J Tongji Med Univ Tong Ji Yi Ke Xue Xue Bao 17:160–164 Wu H, Zheng O, Du J et al (1997) A new drug delivery system—Ciprofloxacine/tricalcium phosphate delivery capsule (CTDC) and its in vitro drug release pattern. J Tongji Med Univ Tong Ji Yi Ke Xue Xue Bao 17:160–164
30.
go back to reference Shinto Y, Uchida A, Korkusuz F et al (1992) Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 74:600–604 Shinto Y, Uchida A, Korkusuz F et al (1992) Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br 74:600–604
31.
go back to reference Galois L, Mainard D, Cohen P et al (2000) Comblement des pertes de substance osseuse par le phosphatetricalcique en traumatologie. Ann Chir 125:972–981CrossRef Galois L, Mainard D, Cohen P et al (2000) Comblement des pertes de substance osseuse par le phosphatetricalcique en traumatologie. Ann Chir 125:972–981CrossRef
32.
go back to reference Pham HH, Luo P, Génin F, Dash AK (2002) Synthesis and characterization of hydroxyapatite-Ciprofloxacin delivery systems by precipitation and spray drying technique. AAPS PharmSciTech 3:1–9. doi:10.1208/pt030101 CrossRef Pham HH, Luo P, Génin F, Dash AK (2002) Synthesis and characterization of hydroxyapatite-Ciprofloxacin delivery systems by precipitation and spray drying technique. AAPS PharmSciTech 3:1–9. doi:10.​1208/​pt030101 CrossRef
33.
go back to reference Nayak AK, Sen S (2009) Hydroxyapatite. Ciprofloxacin minipellets for bone-implant delivery: preparation, characterization, In-vitro drug adsorption and dissolution studies. Int J Drug Dev Res 1:47–59 Nayak AK, Sen S (2009) Hydroxyapatite. Ciprofloxacin minipellets for bone-implant delivery: preparation, characterization, In-vitro drug adsorption and dissolution studies. Int J Drug Dev Res 1:47–59
34.
go back to reference Nayak AK, Bhattacharyya A, Sen KK (2011) In Vivo ciprofloxacin release from hydroxyapatite-based bone implants in rabbit tibia: a preliminary study. Int Sch Res Not 2011:e420549. doi:10.5402/2011/420549 Nayak AK, Bhattacharyya A, Sen KK (2011) In Vivo ciprofloxacin release from hydroxyapatite-based bone implants in rabbit tibia: a preliminary study. Int Sch Res Not 2011:e420549. doi:10.​5402/​2011/​420549
35.
go back to reference Bui XV, Oudadesse H, Le Gal Y et al (2011) Microspheres of chitosan-bioactive glass for application in orthopedic surgery. In vitro experiment. Recent Res Mod, Med Bui XV, Oudadesse H, Le Gal Y et al (2011) Microspheres of chitosan-bioactive glass for application in orthopedic surgery. In vitro experiment. Recent Res Mod, Med
38.
go back to reference Fu Q, Zhou N, Huang W et al (2004) Formation and characterization of bone-like nanoscale hydroxyapatite in glass bone cement. J Mater Sci Technol 20:702–774 Fu Q, Zhou N, Huang W et al (2004) Formation and characterization of bone-like nanoscale hydroxyapatite in glass bone cement. J Mater Sci Technol 20:702–774
39.
go back to reference Jebahi S, Oudadesse H, Faouzi F et al (2013) Osteoinduction and antiosteoporotic performance of hybrid biomaterial chitosan–bioactive glass graft: effects on bone remodeling. J Mater Sci Eng. doi:10.4172/2169-0022.1000128 Jebahi S, Oudadesse H, Faouzi F et al (2013) Osteoinduction and antiosteoporotic performance of hybrid biomaterial chitosan–bioactive glass graft: effects on bone remodeling. J Mater Sci Eng. doi:10.​4172/​2169-0022.​1000128
40.
go back to reference Trecant M, Guicheux J, Grimandi G et al (1997) Dynamic compaction : a new process to compact therapeutic agent-loaded calcium phosphates. Biomaterials 18:141–145CrossRef Trecant M, Guicheux J, Grimandi G et al (1997) Dynamic compaction : a new process to compact therapeutic agent-loaded calcium phosphates. Biomaterials 18:141–145CrossRef
41.
go back to reference Kawanabe K, Okada Y, Matsusue Y et al (1998) Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg Br 80:527–530CrossRef Kawanabe K, Okada Y, Matsusue Y et al (1998) Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg Br 80:527–530CrossRef
42.
go back to reference Solberg BD, Gutow AP, Baumgaertner MR (1999) Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 13:102–106CrossRef Solberg BD, Gutow AP, Baumgaertner MR (1999) Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model. J Orthop Trauma 13:102–106CrossRef
43.
go back to reference Nelson CL, McLaren SG, Skinner RA et al (2002) The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res Off Publ Orthop Res Soc 20:643–647. doi:10.1016/S0736-0266(01)00133-4 CrossRef Nelson CL, McLaren SG, Skinner RA et al (2002) The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res Off Publ Orthop Res Soc 20:643–647. doi:10.​1016/​S0736-0266(01)00133-4 CrossRef
44.
go back to reference McLaren AC (2004) Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop 427:101–106CrossRef McLaren AC (2004) Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop 427:101–106CrossRef
45.
go back to reference Baro M, Sánchez E, Delgado A et al (2002) In vitro-in vivo characterization of gentamicin bone implants. J Control Release Off J Control Release Soc 83:353–364CrossRef Baro M, Sánchez E, Delgado A et al (2002) In vitro-in vivo characterization of gentamicin bone implants. J Control Release Off J Control Release Soc 83:353–364CrossRef
47.
go back to reference Koort JK, Mäkinen TJ, Suokas E et al (2005) Efficacy of Ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 49:1502–1508. doi:10.1128/AAC.49.4.1502-1508.2005 CrossRef Koort JK, Mäkinen TJ, Suokas E et al (2005) Efficacy of Ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 49:1502–1508. doi:10.​1128/​AAC.​49.​4.​1502-1508.​2005 CrossRef
48.
go back to reference Mäkinen TJ, Veiranto M, Lankinen P et al (2005) In vitro and in vivo release of Ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063–1068. doi:10.1093/jac/dki366 CrossRef Mäkinen TJ, Veiranto M, Lankinen P et al (2005) In vitro and in vivo release of Ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063–1068. doi:10.​1093/​jac/​dki366 CrossRef
49.
go back to reference Huddleston PM, Steckelberg JM, Hanssen AD et al (2000) Ciprofloxacin inhibition of experimental fracture healing. J Bone Jnt Surg Am 82:161–173CrossRef Huddleston PM, Steckelberg JM, Hanssen AD et al (2000) Ciprofloxacin inhibition of experimental fracture healing. J Bone Jnt Surg Am 82:161–173CrossRef
51.
go back to reference Haleem AA, Rouse MS, Lewallen DG et al (2004) Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop 427:22–24CrossRef Haleem AA, Rouse MS, Lewallen DG et al (2004) Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop 427:22–24CrossRef
Metadata
Title
In vivo study of hybrid biomaterial scaffold bioactive glass–chitosan after incorporation of Ciprofloxacin
Authors
Salha Boulila
Hassane Oudadesse
Rim Kallel
Bertrand Lefeuvre
Mostafa Mabrouk
Khansa Chaabouni
Fatma Makni-Ayedi
Tahia Boudawara
Abdelfattah Elfeki
Hafed Elfeki
Publication date
23-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Polymer Bulletin / Issue 10/2017
Print ISSN: 0170-0839
Electronic ISSN: 1436-2449
DOI
https://doi.org/10.1007/s00289-017-1936-z

Other articles of this Issue 10/2017

Polymer Bulletin 10/2017 Go to the issue

Premium Partners